Determining the reporting quality of RCTs in clinical pharmacology
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background The Consolidated Standards for Reporting Trials (CONSORT) are recommendations for improving the quality of reports of randomized controlled trials (RCTs). Objective To determine the extent to which clinical pharmacology journals implement specific CONSORT recommendations. Design and setting Analysis of RCTs published between May 2002 and May 2003 in four clinical pharmacology journals. Main outcome measures Proportion of RCTs that published a participant flow diagram and that reported on randomization and restriction methods, allocation concealment, blinding, intention‐to‐treat analysis, ethical considerations, adverse events and source of funding. Results Of 482 clinical trials, 193 were RCTs. Healthy participants were involved in 129 [66.8%, 95% confidence interval (CI) 59.9, 73.1] trials, patients who required treatment in 61 (31.6%, 95% CI 25.4, 38.4) trials and both in three (1.6%, 95% CI 0.5, 4.4) trials. The following items were infrequently reported: sequence generation (17%), allocation concealment (3%), use of restriction (16%), description of blinding (26%), and flow diagrams of study participants (2%). In contrast, the following areas were often reported: use of intention‐to‐treat analysis (79%), description of withdrawals (92.2%) and description of adverse events (71%), ethics review (94%) and informed consent (95%). Sources of funding were reported in 56% of studies. Conclusion The use of the selected CONSORT items is limited in these journals, possibly as many items may not be relevant to the types of studies published in clinical pharmacology journals. Further efforts are required to determine the applicability of CONSORT to RCTs in clinical pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
The Intention-to-Treat Principle: How to Assess the True Effect of Choosing a Medical Treatment
Detry, M. A., & Lewis, R. J. (2014) · JAMA · doi:10.1001/jama.2014.7523 · Cited by 634
Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality
Huwiler-Müntener, K. (2002) · JAMA · doi:10.1001/jama.287.21.2801 · Cited by 397
Value of Flow Diagrams in Reports of Randomized Controlled Trials
Egger, M. (2001) · JAMA · doi:10.1001/jama.285.15.1996 · Cited by 317
Completeness of Safety Reporting in Randomized Trials: An Evaluation of 7 Medical Areas
Ioannidis, J. P. A., & Lau, J. (2001) · JAMA · doi:10.1001/jama.285.4.437 · Cited by 3
Research works printed but not linked: 16
- 10.1016/S0140-6736(00)04337-3 · DOI · Paper page
- 10.1001/jama.287.21.2813 · DOI · Paper page
- Bhandari M, 2002, Application of the Consolidated Standards of Reporting Trials (CONSORT) in the Fracture Care Literature, J Bone Joint Surg Am, 84, 485, 10.2106/00004623-200203000-00023 · DOI · Paper page
- 10.1016/S0197-2456(02)00214-3 · DOI · Paper page
- 10.1001/jama.287.21.2799 · DOI · Paper page
- 10.1001/jama.280.3.280 · DOI · Paper page
- 10.1001/jama.1995.03520290060030 · DOI
- 10.1001/jama.1995.03530180050029 · DOI · Paper page
- 10.1016/S0895-4356(02)00446-8 · DOI · Paper page
- 10.1007/BF00609988 · doi:10.1007/bf00609988
- 10.1001/jama.287.21.2835 · DOI
- Montori VM, 2001, Intention‐to‐treat principle, CMAJ, 165, 1339
- 10.1186/1472-6904-1-3 · DOI
- 10.2307/2529310 · DOI · Paper page
- 10.1136/bmj.328.7430.22 · DOI · Paper page
- 10.7326/0003-4819-138-1-200301070-00012-w1 · DOI · Paper page
Cited by
Clarification of Terminology in Drug Safety
Aronson, J. K., & Ferner, R. E. (2005) · Drug Safety · doi:10.2165/00002018-200528100-00003 · Cited by 328
EQUATOR: reporting guidelines for health research
Altman, D. G., Simera, I., Hoey, J., Moher, D., & Schulz, K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60505-x · Cited by 325
Self-citationGuidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors
Simera, I., Altman, D. G., Moher, D., Schulz, K. F., & Hoey, J. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050139 · Cited by 220
Self-citationMills, E. J., Wu, P., Gagnier, J., & Devereaux, P. J. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.02.008 · Cited by 216
Self-citationUetani, K., Nakayama, T., Ikai, H., Yonemoto, N., & Moher, D. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1358 · Cited by 59
“To improve familiarity, more journals should include the CONSORT statement in their “Information for Authors” and require adherence to the statement for RCT reports (5, 15, 16).”
BackgroundMethodResultSelf-citation
Metadata
- Authors
- Mills, E., Loke, Y. K., Wu, P., Montori, V. M., Perri, D., Moher, D., & Guyatt, G.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2004-06-04
- Volume
- 58
- Issue
- 1
- Pages
- 61-65
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1996131030
- Cited by
- 56
- References
- 5
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determining the reporting quality of RCTs in clinical pharmacology. https://app.cochat.ai/papers/10.1111/j.1365-2125.2004.2092.x
- The paper
- Mills, E., Loke, Y. K., Wu, P., Montori, V. M., Perri, D., Moher, D., & Guyatt, G. (2004). Determining the reporting quality of RCTs in clinical pharmacology. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2004.2092.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.